NovaBay Pharmaceuticals, Inc.
NBY · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,309 | $5,344 | $8,467 | $430 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $368 | $3 | $223 | $389 |
| Inventory | $0 | $467 | $0 | $765 |
| Other Curr. Assets | $221 | $301 | $348 | $351 |
| Total Curr. Assets | $2,898 | $6,115 | $9,038 | $1,935 |
| Property Plant & Equip (Net) | $195 | $317 | $355 | $1,008 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $477 | $477 | $477 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $394 | $2 | $2 | $42,486 |
| Total NC Assets | $589 | $796 | $834 | $43,971 |
| Other Assets | $0 | $0 | $0 | -$42,483 |
| Total Assets | $3,487 | $6,911 | $9,872 | $3,423 |
| Liabilities | – | – | – | – |
| Payables | $76 | $604 | $800 | $623 |
| Short-Term Debt | $565 | $520 | $487 | $963 |
| Tax Payable | $0 | $241 | $290 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $488 |
| Other Curr. Liab. | $807 | $779 | $1,490 | $769 |
| Total Curr. Liab. | $1,448 | $2,144 | $3,067 | $2,843 |
| LT Debt | $405 | $522 | $638 | $709 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $405 | $522 | $638 | $709 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $821 | $931 | $1,041 | $1,107 |
| Total Liabilities | $1,853 | $2,666 | $3,705 | $3,552 |
| Equity | – | – | – | – |
| Pref Stock | $4,317 | $6 | $6 | $6 |
| Common Stock | $60 | $58 | $58 | $49 |
| Retained Earnings | -$183,817 | -$177,709 | -$175,787 | -$183,457 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $181,074 | $181,890 | $181,890 | $183,273 |
| Total Equity | $1,634 | $4,245 | $6,167 | -$129 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $3,487 | $6,911 | $9,872 | $3,423 |
| Net Debt | -$1,339 | -$4,302 | -$7,342 | $1,242 |